Imeglimin
id:
imeglimin-279-534187
title:
Imeglimin
text:
Imeglimin is an oral anti-diabetic medication. It was approved for use in Japan in June 2021. It is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion. It is the first approved drug of this class of anti-diabetic medication.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Imeglimin
date created:
date modified:
2023-09-26T16:44:29Z
main entity:
{"identifier":"Q6003719","url":"https://www.wikidata.org/entity/Q6003719"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/81/Imeglimin.svg","width":512,"height":393}
fields total:
13
integrity:
15